HEALTH RISK OF DRUGS AND ITS IMPACT ON PATIENT ADHERENCE TO MEDICAL TREATMENT
Author(s)
Masarykova L, Lehocka L, Olearova A, Snopkova M, Buszekova B
Comenius University in Bratislava, Faculty of Pharmacy, Bratislava, Slovakia
Presentation Documents
OBJECTIVES: Patient adherence is a basic determinant of any successful treatment. Medication non-adherence is a serious problem influencing not only a patient, but also healthcare systems. The main aim of research was to obtain information about the impact of drug risk, associated with the occurrence of drug-related problems (mainly adverse drug reactions), on patient adherence to drug treatment. METHODS: By a questionnaire survey and applying statistical methods, it was found how the occurrence of adverse drug reactions and patient information leaflet about adverse drug reactions could contribute to patient adherence to drug treatment. RESULTS: In total, 215 respondents were included. There were 69.3% of females and 30.7% of males. According to age, the biggest group of respondents consisted of those aged from 51 to 60 (24%). The most common chronical disease was hypertension followed by osteoporosis and some other diseases, such as gastrointestinal diseases, polyneuropathy and rheumatic diseases. The first question of the questionnaire was about adverse drug reactions after taking medications, which experienced 55.3% of the respondents. And 86.3% of the respondents took their prescribed medications following recommended treatment regimens. Mostly, pharmacists or GPs provided information about that (38.6%). Taking prescribed medications at the wrong time confessed 60.5% of the respondents. The information on adverse drug reactions in written form discouraged 31.6% of the respondents from taking medications. The most common reason to non-adherence, or better to say, to quit taking prescribed medications was the awareness of ADRs (44%). CONCLUSIONS: The research shows that the risk of drugs associated with potential drug-related problems (mainly adverse drug reactions) contributes significantly to patient poor adherence to drug treatment, according to 44% of the respondents. It is a lot and can be enhanced by providing more information on ADRs for patients by pharmacists or general practitioners.
Conference/Value in Health Info
2016-10, ISPOR Europe 2016, Vienna, Austria
Value in Health, Vol. 19, No. 7 (November 2016)
Code
PHP258
Topic
Patient-Centered Research
Topic Subcategory
Adherence, Persistence, & Compliance
Disease
Multiple Diseases